earnings
CR
NASDAQ · CRSP
CRISPR Therapeutics AG
Healthcare · Biotechnology
$59.03
Up+$0.70 (+1.20%)
Updated Sep 23, 2026, 8:46 AM
SID Score
5.0/10
Composite research score
Smart Money
54/100
Neutral
- Market cap
- 5.08B
- P/E ratio
- -10.81
- Dividend yield
- 0.00%
- 52-week range
- $44.12 – $78.48
- Volume
- 2.08M
- Avg. volume
- 2.56M
Price performance
CRSP price history
1M range · 20 trading sessions · Daily adjusted prices
CRSP closed at $59.03 after 20 trading sessions, down 3.07% for the selected period.
- Last close
- $59.03
- Period change
- -3.07%
- Period low
- $51.72
- Period high
- $60.90
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 22, 2026 | $58.73 | $60.72 | $57.64 | $59.03 | 2.08M |
| Sep 21, 2026 | $57.98 | $59.24 | $56.8666 | $58.33 | 1.81M |
| Sep 18, 2026 | $58.00 | $59.34 | $55.6343 | $56.56 | 3.38M |
| Sep 17, 2026 | $53.90 | $59.21 | $53.12 | $57.325 | 3M |
| Sep 16, 2026 | $52.16 | $53.67 | $51.83 | $52.21 | 2.67M |
| Sep 15, 2026 | $52.57 | $52.845 | $51.49 | $51.83 | 1.25M |
| Sep 14, 2026 | $51.33 | $53.80 | $51.33 | $52.96 | 1.53M |
| Sep 11, 2026 | $52.35 | $53.21 | $51.62 | $51.72 | 856.71K |
| Sep 10, 2026 | $52.50 | $52.625 | $51.72 | $52.26 | 1.26M |
| Sep 9, 2026 | $54.595 | $54.90 | $53.31 | $53.45 | 1.18M |
| Sep 8, 2026 | $54.45 | $55.10 | $52.78 | $54.78 | 1.39M |
| Sep 4, 2026 | $56.06 | $57.21 | $55.35 | $55.79 | 904.29K |
| Sep 3, 2026 | $57.50 | $57.80 | $55.7201 | $56.49 | 1.49M |
| Sep 2, 2026 | $57.13 | $58.9627 | $55.5919 | $56.92 | 911.12K |
| Sep 1, 2026 | $56.22 | $57.13 | $55.43 | $56.82 | 890.82K |
| Aug 31, 2026 | $56.55 | $57.49 | $56.20 | $56.98 | 1.39M |
| Aug 28, 2026 | $58.22 | $59.3699 | $57.10 | $57.72 | 1.39M |
| Aug 27, 2026 | $59.12 | $60.11 | $58.02 | $59.37 | 1.19M |
| Aug 26, 2026 | $60.18 | $60.39 | $58.06 | $59.23 | 959.93K |
| Aug 25, 2026 | $57.93 | $61.55 | $57.5103 | $60.90 | 2.08M |
Latest CRSP news
The latest Smart Investors Daily articles mentioning CRSP.
Stock researchResearch & News · SID Coverage
Loading stock research…